KOENIG DAVID 4

4 · ProUroCare Medical Inc. · Filed Aug 12, 2010

Form 4

Period: 2010-08-10

Director

Transactions

Award
Stock Options
2010-08-10+14,535→ 14,535 total
Exercise: $1.72Exp: 2017-08-10→ Common stock, $0.00001 par value (14,535 underlying)

Holdings

Common Stock, $0.00001 par value
(indirect: Shares held by Clinical Network Management Corp., of which reporting person is a managing officer.)
1,875
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (50,000 underlying)
50,000
Warrants
Exercise: $1.30Exp: 2013-08-02→ Common stock, $0.00001 par value (50,000 underlying)
50,000
Common Stock, $0.00001 par value
(indirect: Shares held by Clinical Network Inc., of which the reporting person is a managing officer.)
26,571
Common stock, $0.00001 par value
131,852
Stock Options
Exercise: $11.33Exp: 2012-04-19→ Common Stock, $0.00001 par value (3,000 underlying)
3,000

Footnotes (3)

[F1]Currently exercisable.
[F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
[F3]Annual option award pursuant to the Issuer's compensation policy for Directors upon re-election to the Board of Directors at its annual shareholders' meeting. The seven-year options vest immediately, and the $1.72 exercise price was set at the average of the close bid and asked prices quoted for the Issuer's common stock on the date of the annual meeting.

Documents

1 file